XSPRAY PHARMA Trademark

Trademark Overview

On Thursday, December 16, 2021, a trademark application was filed for XSPRAY PHARMA with the United States Patent and Trademark Office. The USPTO has given the XSPRAY PHARMA trademark a serial number of 97175755. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by Xspray Pharma AB. The XSPRAY PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, protein kinase inhibitors
xspray pharma

General Information

Serial Number97175755
Word MarkXSPRAY PHARMA
Filing DateThursday, December 16, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, protein kinase inhibitors
NOT AVAILABLE"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXspray Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE
Party NameXspray Pharma AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSolna SE-16967
SE

Trademark Events

Event DateEvent Description
Monday, May 9, 2022ASSIGNED TO EXAMINER
Monday, December 20, 2021NEW APPLICATION ENTERED
Tuesday, December 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 10, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 17, 2022ASSIGNED TO LIE
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 6, 2023SOU EXTENSION 1 GRANTED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2023SOU EXTENSION 1 FILED
Tuesday, July 25, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 25, 2023SOU EXTENSION 2 FILED
Tuesday, July 25, 2023SOU EXTENSION 2 GRANTED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 8, 2024SOU EXTENSION 3 FILED
Thursday, February 8, 2024SOU EXTENSION 3 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 30, 2024SOU EXTENSION 4 FILED
Friday, February 14, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

pharma xspray inhibitors kinase protein namely pharmaceuticals